NZ599006A - Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof - Google Patents

Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Info

Publication number
NZ599006A
NZ599006A NZ599006A NZ59900610A NZ599006A NZ 599006 A NZ599006 A NZ 599006A NZ 599006 A NZ599006 A NZ 599006A NZ 59900610 A NZ59900610 A NZ 59900610A NZ 599006 A NZ599006 A NZ 599006A
Authority
NZ
New Zealand
Prior art keywords
methyl
formula
fluoro
indazol
dihydropyridine
Prior art date
Application number
NZ599006A
Other languages
English (en)
Inventor
Alexandros Vakalopoulos
Maria Kissel
Donald Bierer
Martin Michels
Katja Zimmermann
Nicole Teusch
Karen Engel
Markus Follmann
Mario Lobell
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of NZ599006A publication Critical patent/NZ599006A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NZ599006A 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof NZ599006A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172304 2009-10-06
PCT/EP2010/064648 WO2011042368A1 (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
NZ599006A true NZ599006A (en) 2013-11-29

Family

ID=43357944

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ599006A NZ599006A (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Country Status (27)

Country Link
US (1) US9422263B2 (https=)
EP (1) EP2485726B1 (https=)
JP (1) JP5753175B2 (https=)
KR (1) KR20120091005A (https=)
CN (1) CN102573838B (https=)
AR (1) AR078486A1 (https=)
AU (1) AU2010305550A1 (https=)
BR (1) BR112012006842A2 (https=)
CA (1) CA2773676C (https=)
CL (1) CL2012000753A1 (https=)
CR (1) CR20120150A (https=)
CU (1) CU20120051A7 (https=)
DO (1) DOP2012000085A (https=)
EC (1) ECSP12011748A (https=)
ES (1) ES2458117T3 (https=)
IL (1) IL218415A0 (https=)
IN (1) IN2012DN02675A (https=)
MX (1) MX2012003603A (https=)
NZ (1) NZ599006A (https=)
PE (1) PE20121392A1 (https=)
PH (1) PH12012500640A1 (https=)
RU (1) RU2012111695A (https=)
SG (1) SG178990A1 (https=)
TW (1) TW201124396A (https=)
UY (1) UY32922A (https=)
WO (1) WO2011042368A1 (https=)
ZA (1) ZA201201524B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650179Y2 (ja) 1989-06-01 1994-12-21 株式会社プラコー ブロー成形機用のダイヘッド
JPH0756186Y2 (ja) 1989-07-24 1995-12-25 株式会社日本製鋼所 パリソンの押出成形装置
JP2781376B2 (ja) 1996-06-17 1998-07-30 エクセル株式会社 中空成形品
DE102009056886A1 (de) * 2009-12-03 2011-06-09 Bayer Schering Pharma Aktiengesellschaft cMet-Inhibitoren zur Behandlung der Endometriose
SG11202108636SA (en) 2019-02-11 2021-09-29 Merck Patent Gmbh Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
DE59009485D1 (de) 1989-01-26 1995-09-14 Bayer Ag Optisch aktive (Meth)Acrylsäure-Derivate, ihre Herstellung, ihre Polymerisation zu optisch aktiven Polymeren und deren Verwendung.
DE19546136A1 (de) 1995-12-11 1997-06-12 Bayer Ag Chirale stationäre Phasen für die chromatographische Trennung von optischen Isomeren
US7429609B2 (en) 2002-05-31 2008-09-30 Eisai R & D Management Co., Ltd. Pyrazole compound and medicinal composition containing the same
JP2007526324A (ja) 2004-03-02 2007-09-13 スミスクライン・ビーチャム・コーポレイション Akt活性のある阻害剤
EP1722792A1 (de) 2004-03-03 2006-11-22 Boehringer Ingelheim International GmbH Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
KR20070087602A (ko) 2004-12-13 2007-08-28 아이알엠 엘엘씨 화합물 및 스테로이드성 수용체 및 칼슘 채널 활성의조절제로서의 조성물
EP1858325A4 (en) 2005-01-07 2010-06-30 Roskamp Res Llc COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION AND METHODS FOR IDENTIFYING THESE COMPOUNDS
US7632839B2 (en) * 2005-01-19 2009-12-15 Merck & Co. Inc. Mitotic kinesin inhibitors
EA200900779A1 (ru) * 2006-12-14 2010-02-26 Байер Шеринг Фарма Акциенгезельшафт Производные дигидропиридина, полезные как ингибиторы протеинкиназы

Also Published As

Publication number Publication date
US20120264785A1 (en) 2012-10-18
AU2010305550A1 (en) 2012-03-29
EP2485726A1 (en) 2012-08-15
PH12012500640A1 (en) 2012-11-12
IL218415A0 (en) 2012-04-30
MX2012003603A (es) 2012-04-20
CN102573838B (zh) 2014-09-24
PE20121392A1 (es) 2012-10-14
EP2485726B1 (en) 2014-03-12
CU20120051A7 (es) 2012-06-29
KR20120091005A (ko) 2012-08-17
HK1172835A1 (en) 2013-05-03
ECSP12011748A (es) 2012-05-30
SG178990A1 (en) 2012-04-27
JP5753175B2 (ja) 2015-07-22
RU2012111695A (ru) 2013-10-10
UY32922A (es) 2011-04-29
CA2773676C (en) 2017-07-04
DOP2012000085A (es) 2012-07-15
TW201124396A (en) 2011-07-16
ES2458117T3 (es) 2014-04-30
CL2012000753A1 (es) 2012-09-14
WO2011042368A1 (en) 2011-04-14
IN2012DN02675A (https=) 2015-09-04
CA2773676A1 (en) 2011-04-14
CN102573838A (zh) 2012-07-11
ZA201201524B (en) 2013-05-29
AR078486A1 (es) 2011-11-09
CR20120150A (es) 2012-08-03
US9422263B2 (en) 2016-08-23
JP2013506699A (ja) 2013-02-28
BR112012006842A2 (pt) 2016-06-07

Similar Documents

Publication Publication Date Title
NZ599006A (en) Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
DK2091948T3 (da) Nye inhibitorer af glutaminylcyclase
Zhang et al. Photocatalyzed Minisci-type reactions for late-stage functionalization of pharmaceutically relevant compounds
CR10784A (es) Nuevos derivados de aminopirimidina como inhibidores de plki
PL2428519T3 (pl) Kompozycja do wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
NZ599444A (en) Novel heterocyclic acrylamides and their use as pharmaceuticals
MY150514A (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
EP3456721A3 (en) Method of producing compounds having hiv integrase inhivitory activity
MX2007004215A (es) Proceso para la sintesis de 4-(3-metansulfonilfenil)-1-n- propilpiperidina.
WO1999059971A1 (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
PE20100155A1 (es) Derivados de urea heterociclicos y metodos de uso de los mismos-332
JP2012507525A5 (https=)
MX362102B (es) Método para producir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il]pir idina-2-carbonitrilo e intermediario del mismo.
TW200540158A (en) Novel hydroxy-6-heteroarylphenanthridines
NZ599747A (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
CN102120732B (zh) 高哌嗪及其衍生物的制备方法
PL1874762T3 (pl) Sposób otrzymywania 5-(4-[4-(5-cyjano-3-indolilo)butylo]-1-piperazynylo)benzofurano-2-karboksyamidu
MX2009010727A (es) Heterociclos como antagonistas de orexina.
EA200700360A1 (ru) Новые производные амида гетероциклической карбоновой кислоты
NO20063747L (no) Substituerte kinoliner og deres anvendelse som mykobakterielle inhibitorer
NO20084691L (no) Piperidinerivater som er nyttige for bahandling av osteoarttitt og osteoartrose
AR118649A1 (es) Opciones sintéticas hacia la fabricación de (6r,10s)-10-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1(6h)-pirimidinil}-1-(difluorometil)-6-metil-1,4,7,8,9,10-hexahidro-11,15-(meteno)pirazol[4,3-b][1,7]diazaciclotetradecin-5(6h)-ona
PL2234974T3 (pl) Sposób otrzymywania związku (s)-1-alkilo-2', 6'-pipekoloksylidydu
EP1948646A2 (en) Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Effective date: 20130815

PSEA Patent sealed
LAPS Patent lapsed